Isofol Medical AB (publ) (STO:ISOFOL)
Sweden · Delayed Price · Currency is SEK 0.8780
-0.0150 (-1.68%)
Aug 13, 2026, 5:29 PM CET
Isofol Medical AB Market Cap
Isofol Medical AB has a market cap or net worth of 286.2 million as of August 13, 2026. Its market cap has increased by 18.39% in one year.
Market Cap
286.20M
Enterprise Value
175.46M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.88
ChartMarket Cap Chart
Since April 4, 2017, Isofol Medical AB's market cap has decreased from 853.32M to 286.20M, a decrease of -66.46%. That is a compound annual growth rate of -11.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 286.20M | 39.66% |
| Dec 30, 2025 | 204.93M | -42.85% |
| Dec 30, 2024 | 358.56M | 204.11% |
| Dec 29, 2023 | 117.91M | -1.35% |
| Dec 30, 2022 | 119.52M | -91.99% |
| Dec 30, 2021 | 1.49B | -36.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 4, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Corline Biomedical AB | 482.16M |
| Cantargia AB | 449.49M |
| Mendus AB | 423.81M |
| Intervacc AB | 408.98M |
| Sprint Bioscience AB | 340.82M |
| IRLAB Therapeutics AB | 234.07M |
| Xbrane Biopharma AB | 200.28M |
| Elicera Therapeutics AB | 197.87M |